BSG and thyroid gland carcinoma: In detail, upregulated BSG expression was observed in 14 cancers: BLCA, invasive breast carcinoma (BRCA), cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSCC), kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIRP), LIHC, LUAD, LUSC, prostate adenocarcinoma (PRAD), stomach adenocarcinoma (STAD), thyroid carcinoma (THCA), and uterine corpus endometrial carcinoma (UCEC); downregulated BSG expression was detected in two cancers: colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) (p < 0.05; Figure 2C).